FDA
approval
· 2021-01-06
FDA Approved: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)
Summary
The FDA approved Teva Respiratory's supplemental application for QVAR REDIHALER (beclomethasone dipropionate HFA). The action pertains to a supplement for this …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)